BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10757801)

  • 1. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L; Gunter DR; Herrington J; Carter-Su C
    Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
    Rui L; Carter-Su C
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
    Rui L; Mathews LS; Hotta K; Gustafson TA; Carter-Su C
    Mol Cell Biol; 1997 Nov; 17(11):6633-44. PubMed ID: 9343427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH2-B is required for growth hormone-induced actin reorganization.
    Herrington J; Diakonova M; Rui L; Gunter DR; Carter-Su C
    J Biol Chem; 2000 Apr; 275(17):13126-33. PubMed ID: 10777618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    J Endocrinol; 2005 May; 185(2):301-6. PubMed ID: 15845922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Stofega MR; Herrington J; Billestrup N; Carter-Su C
    Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2-Bbeta is a Rac-binding protein that regulates cell motility.
    Diakonova M; Gunter DR; Herrington J; Carter-Su C
    J Biol Chem; 2002 Mar; 277(12):10669-77. PubMed ID: 11786545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.
    O'Brien KB; Argetsinger LS; Diakonova M; Carter-Su C
    J Biol Chem; 2003 Apr; 278(14):11970-8. PubMed ID: 12551917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2-B family members differentially regulate JAK family tyrosine kinases.
    O'Brien KB; O'Shea JJ; Carter-Su C
    J Biol Chem; 2002 Mar; 277(10):8673-81. PubMed ID: 11751854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
    Carter-Su C; Rui L; Stofega MR
    Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.
    Kurzer JH; Saharinen P; Silvennoinen O; Carter-Su C
    Mol Cell Biol; 2006 Sep; 26(17):6381-94. PubMed ID: 16914724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
    Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
    Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH2-B is required for nerve growth factor-induced neuronal differentiation.
    Rui L; Herrington J; Carter-Su C
    J Biol Chem; 1999 Apr; 274(15):10590-4. PubMed ID: 10187854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA; Waxman DJ
    J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.